To perform an early phase feasibility analysis in order to identify the key clinical and economic issues for a successful launch of digital health and AI in the key markets, including clinical, health economic and policy hurdles.

The preparation of the project plan and reimbursement dossier for submission in each country and manage timing and communications with the relevant agencies.

The development of key components of the reimbursement dossier: clinical section, cost-effectiveness and budget impact section. We will ensure that the clinical part of the reimbursement dossier and the economic parts are aligned, especially with regard to the claims, comparator(s) and value messages.

Development of multicountry health economic models and country-specific model adaptations for existing models including the full spectrum of diseases for all countries.

Various animations for diverse applications:

• Explanatory animation for training solutions (for medication usage or new equipment), supported by A2M’s substantive knowledge of the medical field.

• Explanatory animation for investors (demonstrating how the medication or service works and its benefits), informed by A2M’s economic and market access analyses.

• Explanatory animation for users (illustrating correct medication usage), incorporating direct input from A2M’s clinical and health economic expertise.

Moving images provide an effective way to showcase a company or product. A2M and Firma Buurman collaborate on:

• Corporate films that highlight both A2M’s mission and vision and the creative capabilities of Firma Buurman.

• Interviews and press events where complex healthcare themes are translated into understandable content.

• Instructional videos and TV commercials that capture attention with visually appealing and content-rich messages.